“With the availability of new treatments that can delay or prevent disease progression, the opportunity to dramatically change the future of this disease through screening is enormous. By detecting high-risk individuals at an early stage, they will be able to benefit from possible future curatives treatments and look into a future without [type 1] diabetes.”
DiaUnion postdoc Julie Hviid Klæbel, recipient of the Diabetesforeningen research grant 2024, to the Diabetes Behandler magazine. Read the full article here.
